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Abstract
Introduction Coarctation of the aorta in children un-
der 3 months of age is usually treated surgically. How-
ever, there are clinical scenarios in which stenting of
native or recurrent coarctation may become necessary
in this age group.
Case reports Four cases illustrate possible indications:
left ventricular dysfunction increasing the operative
risk, thrombus formation after coarctation surgery,
patient size (i.e. in premature babies), and retrograde
arch obstruction after hybrid palliation of hypoplastic
left heart syndrome. In all babies, coarctation stenting
was carried out successfully without complications.
Conclusion Coarctation stenting can be carried out
safely in small children. Usually, the stent has to be
removed or redilated later. Results are encouraging.
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Introduction
In babies under 3 months of age, coarctation of the
aorta is usually treated surgically in the first instance.
However, there are scenarios in which alternative
treatment is indicated either due to unfavourable
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results after initial surgery, or due to patient charac-
teristics.
Stenting of coarctation of the aorta (CoA) is well es-
tablished in adults and children weighing more than
25kg, but even in smaller children this technique is
gaining acceptance [1, 2]. In smaller children aged
3 months or more, ballooning is a treatment option
for native and recurrent CoA [3], but there are recent
reports of even smaller patients undergoing stent ther-
apy as either a bridge to operation or as primary treat-
ment [4–9]. Stenting of coarctations in small children
has been carried out for several reasons in a limited
number of patients [4–8, 10].
In patients undergoing a hybrid procedure for hy-
poplastic left heart syndrome or borderline left ven-
tricles, stenting of the descending arch may become
necessary to facilitate adequate reverse flow into the
aortic arch, should the ductal stent cover the distal
aortic arch [9].
We describe four cases of CoA stenting carried out
in children under 3 months of age, in each one for
a different reason. We think that these cases illus-
trate typical indications, which are: (1) severely im-
paired left ventricular function, where surgery as pri-
mary treatment carries a high risk; (2) postoperative
thrombus formation within the operated area of the
aorta; (3) prematurity in babies in whom surgery is
What’s new?
 Stenting of (re-)coarctations can be carried out
with good results even in very small children.
 The stents will have to be removed or redilated
later.
 Angiography to delineate the anatomy can be
carried out from the femoral sheath with good
image quality.
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postponed until a higher weight is reached; and fi-
nally (4) potential obstruction of the connection of
the descending aortic arch to the ductal arch in pa-
tients after hybrid therapy for hypoplastic left heart
syndrome and variants.
Case reports
Case 1
A female patient, in whom CoA resection with aor-
tic arch plasty with a homograft patch had been
performed on day 10 of life, was admitted aged
2.5 months (5.3kg) with severe (pinpoint) re-coarc-
tation (Fig. 1a) and extremely poor function of the
dilated left ventricle (fractional shortening 4%) on
echocardiography (Electronic Supplementary Mate-
rial, Movie 1). Dobutamine and adrenaline were
started. Surgery was deemed high risk. The baby
was brought immediately to the catheter laboratory.
Ballooning of the re-coarctation had no effect. Via
a 6F sheath, angiography was performed without an
additional catheter, confirming severe re-coarctation.
This was passed with a 0.014′′ Ironman wire (Abbott,
St Paul, MN, USA), and a short Cook Formula stent
(6× 12mm) (Cook Medical, Bloomington, IN, USA)
was implanted (Fig. 1b), abandoning the invasively
measured blood pressure gradient of 80mmHg com-
pletely. Inotropic support could be weaned within
1 day. Within 2 days ventricular function recovered
to a fractional shortening of 24% (Electronic Supple-
mentary Material, Movie 2). No clinical problems
occurred during follow-up, especially no access-re-
lated problems. Redilation is planned dependent on
blood pressure gradients, but has not been necessary
over 15 months following the procedure.
Case 2
A female patient (3.3kg) underwent coarctectomy
with end-to-end anastomosis on day 14 of life. Post-
operatively, thrombus formation occurred on the
Fig. 1 a, b Baby with se-
vere re-coarctation 6 weeks
after coarctectomy. a In-
jection into the aortic arch.
The re-coarctation is com-
pletely obstructed by the 4F
catheter (arrow). Collateral
arteries are marked with
asterisks. b With a Cook
Formula stent in situ the lu-
men is unobstructed and
continuity restored (arrow).
Collateral flow is hardly vis-
ible anymore
anastomosis site, which appeared on echocardiogra-
phy as an echodense area of the inner curvature of the
arch with an irregular surface (Fig. 2a). Redo surgery
was performed, but was again followed by thrombus
formation. Through a 4F sheath in the femoral artery,
angiography was performed (Fig. 2b), confirming the
thrombus in the transverse arch. A Resolute Onyx
stent 4.5× 8mm (Medtronic, Fridley, MN, USA) was
placed between the left carotid artery and the left
subclavian artery, compressing the residual throm-
bus into the vessel wall (Fig. 2b). The child received
low-molecular-weight heparin subcutaneously, until
2 months later the stent was removed surgically and
an aortic arch plasty was carried out with a homograft
patch. We did not observe access-related problems.
Unfortunately, the child developed re-coarctation dis-
tal to the left subclavian artery 5 months later, which
was treated with balloon dilation. Further follow-up
was uneventful.
On careful review of all the data, the only vari-
ance from standard operative treatment was the use
of a different aortic clamp than is usually used during
surgery. However, it is not clear if this affected throm-
bogenicity inside the vessel, as no dissection flap was
found during redo surgery or on angiography. Further
laboratory testing did not reveal any thrombopathy,
and the further course was uneventful in this respect.
Case 3
A premature male of 33 weeks’ gestation, a second
twin (Apgar scores 2/8/9, birthweight 1.715kg), had
coarctation with a concomitant perimembranous ven-
tricular septal defect. Prostaglandin E infusion was
initiated for 6 weeks to achieve further growth. An in-
tervention was planned to facilitate surgery at a later
stage. This was carried out at a corrected gestational
age of 38 weeks (weight 2.2kg). Via a 4F sheath, an-
giography was carried out, delineating the anatomy
(Fig. 3a). An Onyx stent 4× 8mm (Medtronic) was im-
planted without a long sheath (Fig. 3b), abandoning
the gradient of 50mmHg completely. Three months
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Fig. 2 a Echocardiographic image of the aortic arch. Note
the thrombus presenting as an irregular shape at the inner cur-
vature, which is echodense. b Hand injection into the trans-
verse arch. Arrow Less contrast in the distal arch representing
thrombus (also confirmed on echocardiography). c Stent in
the transverse arch, no residual thrombus visible
later the stent was removed and an extended end-to-
end anastomosis was performed. The child is doing
well 14 months later, with no residual or recurrent CoA
and no access-related problems.
Case 4
A 10-week-old girl weighing 4kg with a borderline left
ventricle (not apex-forming after birth, aortic valve
diameter 5mm, Z-score –2.8) had undergone a hy-
brid approach with bilateral pulmonary artery band-
ing and placement of a self-expanding stent (Sinus-
flex-DS, Optimed, Ettlingen, Germany) in the arterial
duct at the age of 5 days, and an additional Sinus-
flex-DS stent due to constriction of the distal duc-
tal arch at the age of 5 weeks. There was antegrade
flow over the aortic arch, but on echocardiography
the distal aortic arch at the connection to the ductal
arch seemed stenosed with increasing flow velocity
on conventional Doppler ultrasonography. Angiogra-
phy confirmed the stenosed distal aortic arch (Fig. 4a).
Through the struts of the Sinusflex-DS stent, a 0.014′′
Fig. 3 a, b Premature
baby, native coarctation
and hypoplasia of the de-
scending arch (arrow).
aHand injection through the
femoral sheath delineating
the anatomy. b Onyx stent
in situ. Note the expanded
diameter of the isthmus with
the stent (arrow)
Ironman guidewire (Abbott) was forwarded into the
aortic arch via a 5F TorqVue sheath for stabilisation.
An Onyx stent 5× 9mm (Medtronic) was then carefully
placed and deployed (Fig. 4b). Angiographically, flow
through the distal aortic arch improved. Four weeks
later, the baby underwent biventricular repair consist-
ing of surgical removal of all stents, aortic arch plasty
with homograft, closure of atrial and ventricular sep-
tal defects, and reconstruction of the right ventricular
outflow tract. Five months after this operation, the
aortic arch was redilated with an 8-mm balloon. No
further interventions were performed during the fol-
lowing year.
Discussion
Coarctation stenting can be carried out safely in
small children to facilitate surgery at a later stage, or
for acute postoperative problems. Of course, tech-
nical considerations include the choice of sheaths,
catheters and stents. The smallest sheath possible
should be chosen to avoid access problems, which
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Fig. 4 a, b Baby with bor-
derline left ventricle, sta-
tus after hybrid palliation.
Forward flow through the
aorta. a Catheter placed
through the struts of the
Sinusflex-DS stent, hand
injection. The 4F catheter
completely obstructs the
lumen (arrow). b Onyx stent
placed through the struts
of the Sinusflex-DS stent.
Hand injection into the de-
scending aorta. Note the
washout in the area of the
newly placed stent (arrow),
representing forward flow
from the aortic arch
have been described previously [3]. Through the
sheath, angiography even with dilute contrast can
visualise the whole aorta, avoiding manipulation with
a catheter. In children with a ductal stent in situ
after hybrid palliation for hypoplastic left heart syn-
drome or a borderline left ventricle, a catheter placed
closer to the stenosed aortic segment may be benefi-
cial to delineate the anatomy in detail, and to avoid
interference of the ductal arch filling with contrast.
Coronary guidewires like the Ironman we used in
our case series are typically atraumatic and allow
guidance of the balloon-crimped stent through the
coarctation, giving enough support to the balloon-
stent ensemble.
Stents can be coronary stents or small redilatable
ones which can be deployed through small sheaths.
We used Onyx stents in three of our patients. These
are drug-eluting stents, which are frequently used in
adult coronary interventions. At the time of our in-
terventions, non-drug-eluting stents were not stocked
(and hence not available). An ideal stent in this age
group would be a bioabsorbable one which keeps its
mechanical properties long enough to maintain vessel
patency until, after absorption, no further scaffold is
necessary. Unfortunately, no such stent exists yet. In
our three patients treated with coronary stents, these
were removed completely during further surgery. The
Cook Formula stent can be redilated repeatedly, as
necessary, according to patient size [10]. Redilation is
not possible in self-expanding stents, which therefore
are not recommended in this clinical setting. Pro-
cedural details of all procedures are summarised in
Table 1.
Indications for stent placement in a coarctation in
this age group vary, but this is mainly carried out to
stabilise patients. Of course, one has to take into ac-
count that further interventions or operations are un-
avoidable, because of patient growth.
Our first case demonstrates how left ventricular
function can be impaired by a severe (re-)coarctation,
and how this improved once the stent was placed.
Depending on the duration of the impairment, recov-
ery may take some time before the stent can be sur-
gically removed [11]. In a previously described case,
multi-organ failure recovered completely after coarc-
tation stenting in a newborn, which could be operated
successfully 4 weeks later [6]. We used a short stent,
because during a coarctectomy typically a short aortic
segment has to be removed anyway, and we did not
want to extend the operation, i.e. by patch augmen-
tation of the aorta.
Thrombus formation at the operation site of a coarc-
tation is rare, and can be problematic. Compressing
the thrombus into the vessel wall can be achieved,
but the stent needs to be long enough to cover the
whole thrombus. In our case, a stent of 8mm length
was sufficient. Anticoagulation may be necessary
to avoid recurrent thrombus formation at the stent
site. We opted for subcutaneous heparin, as oral an-
ticoagulation in this age group can be challenging.
Our knowledge to date indicates that this is the first
patient in the literature to successfully undergo treat-
ment for an acute thrombus after coarctation surgery
with a stent. Comparable techniques have been used
to treat thrombotic pulmonary artery occlusion, but
in chronic settings [12].
Patient size may also be an indication; in these
cases stent placement facilitates growth of the patient
until a coarctectomy can be carried out safely. This
has been done in children with a weight as low as
680g [5]. Again, a short stent is preferable to make
the operation as simple as possible; during coarctec-
tomy the stented segment can simply be excised and
end-to-end anastomosis performed. Operations can
be delayed up to 2.5 years, and weight gain can be
normalised until then [5].
In children with hypoplastic left heart syndrome
who have undergone a hybrid procedure either as
a bridge to a Norwood procedure or as the first step
of staged palliation, ‘reverse’ coarctation with obstruc-
tion of the descending arch can cause problems both
for the upper half of the body and coronary perfu-
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Table 1 Demographic data and interventional information
Patient Age
(weeks)
Cardiac diagnosis Extracardiac
diagnosis
Weight at inter-
vention (kg)
Sheath size
(max, F)
Stent used Fluoroscopy
time
(min)
Radiation dose (dose
area product)
(µGy m2)
1 10 CoA n/a 5.3 6 Cook Formula
6× 12mm
6.9 109.8
2 2 CoA n/a 3.3 4 Resolute Onyx
4.5× 8mm
4.0 32.6
3 5 CoA Prematurity
33/40 weeks
2.2 4 Resolute Onyx
4× 8mm
3.0 11.1
4 10 CoA, borderline LV,
s/p hybrid palliation
n/a 4.0 5 Resolute Onyx
5× 9mm
9.3 94.3
CoA coarctation of the aorta, LV left ventricle, s/p status post, Hybrid palliation bilateral pulmonary artery banding and ductal stent
sion, in the case of retrograde perfusion [9]. In these
cases, stenting can be performed through the side
struts of a previously placed self-expandable Sinus-
flex-DS stent. Ballooning alone will not be sufficient,
as the struts have a high tendency to recoil [13]. In
our case, there was forward flow through the aortic
arch, but the technical considerations are the same.
Conclusion
Stenting of native or recurrent coarctations can be car-
ried out even in young children under 3 months of age
for various reasons and with good results. Attention
needs to be paid to sheath size and the stent material
used. If an operation is planned in due course, stents
which are not redilatable can be used. Angiography
can be carried out from the femoral sheath with good
image quality.
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